The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease - Wikidata - wikimedia - TriplyDB

The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease

The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease

http://www.wikidata.org/entity/Q26998401

about

Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening.Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country Epstein-Barr virus strains and variations: Geographic or disease-specific variants?Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survival.Simultaneously increased expression of microRNA-155 and suppressor of cytokine signaling 1 (SOCS1) gene in the peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.Prognostic significance of circulating CD19+ B lymphocytes in EBV-associated nasopharyngeal carcinoma.Multiple Evanescent White Dot Syndrome following Acute Epstein-Barr Virus Infection.Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.Human NF-κB1 Haploinsufficiency and Epstein-Barr Virus-Induced Disease-Molecular Mechanisms and Consequences.Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird's Eye View.The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.Immune Ecosystem of Virus-Infected Host Tissues.Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program.Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV Patients Epstein-Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis

P2860

Q26796086-575FC896-DC32-4685-8C09-030937FE7BD5 Q27313748-D87478BD-605D-4E89-950D-07AA467B3414 Q34671337-743F8785-7F09-459C-A74D-E65707902F07 Q35808018-54CBACAC-C04D-425E-82CD-2D790883B9D3 Q36700342-AD9F9FB7-E8FB-4361-B523-5B160D6EC028 Q38901360-229EE128-B998-40F5-B47F-975BAFCFE748 Q40765681-25B34F0E-1FB4-482B-864B-4D0E8B9A42B8 Q41086936-03EC6F2D-1041-4055-AA99-2BA9FB83588E Q41757247-E1007EEE-2D5E-4FCF-844C-A94CAA66F82D Q41918957-2D695874-9A39-45A1-B84C-7E15B82194E5 Q47547404-BAC9246C-45A3-44B0-A70A-26EBEA54CC5F Q49520325-377A3769-3579-43C2-88BE-541693124022 Q49884884-E1747A96-398D-4B1A-8C85-7D8A088D4EC7 Q52349005-4B8C8339-5268-4C70-9147-F03C58B8E0DB Q55254424-9F948259-8DF8-4BD2-B1F4-806ADD0CD956 Q55263694-C15E720F-1145-4D2F-996B-DAD075DA1921 Q58583848-11DD9B43-84E4-4D85-885C-832BF2503808 Q58803477-62E71E0A-C034-478A-8983-0B31EF423309

P2860

The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease

http://www.wikidata.org/entity/Q26998401

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The interplay between Epstein- ...... fection, immunity, and disease

@ast

The interplay between Epstein- ...... fection, immunity, and disease

@en

The interplay between Epstein- ...... fection, immunity, and disease

@nl

type

label

The interplay between Epstein- ...... fection, immunity, and disease

@ast

The interplay between Epstein- ...... fection, immunity, and disease

@en

The interplay between Epstein- ...... fection, immunity, and disease

@nl

prefLabel

The interplay between Epstein- ...... fection, immunity, and disease

@ast

The interplay between Epstein- ...... fection, immunity, and disease

@en

The interplay between Epstein- ...... fection, immunity, and disease

@nl

P1433

Q26998401-D737ACF4-737D-45DF-BBD5-5D717F792CCE

P1476

Q26998401-E5C2DD9D-9D7E-4810-B7BA-166151E15FBC

P2093

Q26998401-61200F5B-0C38-4328-83F5-668DB3560E5F

Q26998401-8611D675-5455-49F4-872D-337BDB8FABD3

Q26998401-E6FBBB86-6638-4528-AC0D-6B250C9A3944

Q26998401-EA99CBE9-8E4A-470D-999C-A5B1A3F7C499

Q26998401-FC326111-3465-4CCD-980E-591AD7C344DA

P2860

Q26998401-02632B82-96B7-4830-94A2-9A6D30706464

Q26998401-08EF1C0D-A643-4575-B3C7-81C64306F88B

Q26998401-0C8E1461-DD71-4E87-9CFD-8A00EE6CA6CE

Q26998401-0D43CDB9-CA66-4BFC-AE80-751B318D71D0

Q26998401-10A955B9-AEC6-4339-A06D-B27B6872C36E

Q26998401-12A2A092-921C-4CD8-B383-231FD2C582B6

Q26998401-136F2121-1639-4E13-9E4D-03AAA6BBF583

Q26998401-172C2D18-6A63-4447-A34D-2FC189B1D31C

Q26998401-1A38C063-8F2E-43E6-AFCE-155D2E8873D2

Q26998401-1B3B1A6B-4092-4709-9BE6-32C4907FA0E4

P2888

Q26998401-703B36A8-BBD7-4AB4-A54C-E7083DD6ABF9

P304

Q26998401-FCE26670-B61C-4B59-B9F2-ADF49665C4D6

P31

Q26998401-26567AF9-1E95-4C25-84A7-9F949226D9E0

P3181

Q26998401-97F7611C-96AF-4486-B629-36C53DA2DA1F

P356

Q26998401-9FD8AF23-7A8A-4130-A08E-F18188A367E7

P407

Q26998401-CB0BB9F3-0873-4660-B692-BC37033D9703

P433

Q26998401-91A7774D-560F-4E97-B664-C7D9222EC04F

P478

Q26998401-9557C0DA-4FE3-4834-9967-A9FA7A7492F1

P577

Q26998401-2F016EF5-5C33-4611-8A98-8754CE003B55

P6179

Q26998401-97FC257B-B76F-4E6C-9887-9766D5E9022F

P698

Q26998401-9B27E8DA-5A3C-43C5-9CA7-4A7246505936

P921

Q26998401-79D102DE-7A99-4729-B156-6328730BB392

Q26998401-EA97B1B2-4D37-4EC3-8590-206D549580F7

P932

Q26998401-05AB75E6-75B8-4464-AB52-1255728D7BD2

P3181

P356

S12026-014-8496-1

P1433

Immunologic Research

P1476

The interplay between Epstein- ...... fection, immunity, and disease

@en

P2093

Aleishia Harris-Arnold

http://www.w3.org/2001/XMLSchema#string

Olivia L. Hatton

http://www.w3.org/2001/XMLSchema#string

Olivia M. Martinez

http://www.w3.org/2001/XMLSchema#string

Sheri M. Krams

http://www.w3.org/2001/XMLSchema#string

Steven Schaffert

http://www.w3.org/2001/XMLSchema#string

P2860

The viral and cellular microRNA targetome in lymphoblastoid cell lines

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

Identification of virus-encoded microRNAs

Regulation of the germinal center response by microRNA-155

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice

BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation

P2888

s12026-014-8496-1

P304

268-76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1597497

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S12026-014-8496-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1022811686

http://www.w3.org/2001/XMLSchema#string

P698

24619311

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

4199828

http://www.w3.org/2001/XMLSchema#string